Insights into the Interaction between Influenza Virus and Pneumococcus
Open accessThe DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
SUMMARY: Bacterial infections following influenza are an important cause of morbidity and mortality worldwide. Based on the historical importance of pneumonia as a cause of death during pandemic influenza, the increasingly likely possibility that highly pathogenic avian influenza viruses will trigger the next worldwide pandemic underscores the need to understand the multiple mechanisms underlying the interaction between influenza virus and bacterial pathogens such as Streptococcus pneumoniae . There is ample evidence to support the historical view that influenza virus alters the lungs in a way that predisposes to adherence, invasion, and induction of disease by pneumococcus. Access to receptors is a key factor and may be facilitated by the virus through epithelial damage, by exposure or up-regulation of receptors, or by provoking the epithelial regeneration response to cytotoxic damage. More recent data indicate that alteration of the immune response by diminishing the ability of the host to clear pneumococcus or by amplification of the inflammatory cascade is another key factor. Identification and exploration of the underlying mechanisms responsible for this synergism will provide targets for prevention and treatment using drugs and vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As reviewed recently by McCullers [75], a body of experimental research during the last 3 decades has identified possible mechanisms by which coinfection with the influenza virus and bacteria might affect pathogenicity. These include viral neuraminidase (NA)–induced exposure of bacterial adherence receptors; bacterial NA-induced upregulation of influenza infection; interleukin 10–induced suscept”
From Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness (2008) · cites this paper as [75]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Modification of the immune response either by diminishing the ability of the host to clear bacteria or by amplification of the inflammatory cascade is likely to contribute to the severity of the resulting infection.”
From Bacterial and viral infections associated with influenza (2013) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“McCullers shows that from 1968 to 1999 excess deaths directly attributed to pneumonia and influenza (P&I deaths) from selected US cities data were more commonly associated with influenza A(H3N2) rather than H1N1 or influenza B infections.”
From Bacterial and viral infections associated with influenza (2013) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“Streptococcus pneumoniae continues to be the dominant pathogen involved in this synergistic process7 followed mainly by Staphylococcus aureus 5 and Haemophilus influenzae.12, 18”
From Bacterial and viral infections associated with influenza (2013) · cites this paper as [7]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“This suggested that the mechanisms responsible for the effect of influenza virus on pneumococcal colonization might be distinct from those proposed for secondary pneumonia (23).”
From Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice (2011) · cites this paper as [23]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Evolution and ecology of influenza A viruses
Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M., & Kawaoka, Y. (1992) · Microbiological Reviews · doi:10.1128/mr.56.1.152-179.1992 · Cited by 4,739
Tissue Destruction by Neutrophils
Epstein, F. H., & Weiss, S. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200606 · Cited by 3,950 · cited 1×
“Activated neutrophils and macrophages in the lung may contribute to the severity of infection by expression of inflammatory mediators, leading to tissue damage (161), particularly when combined with cytotoxins from the bacteria (24).”
BackgroundMortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Tissue Destruction by Neutrophils
(1989) · New England Journal of Medicine · doi:10.1056/nejm198908033210513 · Cited by 3,631
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293 · cited 1×
“A recently implemented conjugate vaccine is directed against the seven pneumococcal serotypes which most commonly cause invasive disease in the Western world (14).”
BackgroundRecognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,861
Fouchier, R. A. M., Munster, V., Wallensten, A., Bestebroer, T. M., Herfst, S., Smith, D., Rimmelzwaan, G. F., Olsen, B., & Osterhaus, A. D. M. E. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.2814-2822.2005 · Cited by 1,563 · cited 1×
“teen subtypes of HA and nine of NA circulate in wild aquatic birds (48, 160).”
BackgroundInferences, questions and possibilities in Toll-like receptor signalling
Beutler, B. (2004) · Nature · doi:10.1038/nature02761 · Cited by 1,466 · cited 2×
“Pneumolysin is recognized by TLR4 (15, 92), leading to a MyD88-independent signaling cascade mediated by IRF3 and STAT1 but also leading to NF- B activation through TRAF6 (13).”
BackgroundGenesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia
Li, K. S., Guan, Y., Wang, J., Smith, G. J. D., Xu, K. M., Duan, L., Rahardjo, A. P., Puthavathana, P., Buranathai, C., Nguyen, T. D., et al. (2004) · Nature · doi:10.1038/nature02746 · Cited by 1,343
Characterization of the reconstructed 1918 Spanish influenza pandemic virus
Tumpey, T. M., Basler, C. F., Aguilar, P. V., Zeng, H., Solórzano, A., Swayne, D. E., Cox, N. J., Katz, J. M., Taubenberger, J. K., Palese, P., et al. (2005) · Science · doi:10.1126/science.1119392 · Cited by 1,327 · cited 1×
“suggests that the severe lung inflammation seen with the 1918 pandemic strain (154) may be due to increased levels of proinflammatory cytokines and a massive influx of neutrophils into the lung (155).”
BackgroundAvian Influenza A (H5N1) Infection in Humans
(2005) · New England Journal of Medicine · doi:10.1056/nejmra052211 · Cited by 1,285 · cited 3×
“It is feared that another such event may be occurring in Southeast Asia, where avian H5N1 influenza A viruses have become endemic in terrestrial poultry and are being transmitted to humans with increasing frequency (8).”
BackgroundResultYoshimura, A., Lien, E., Ingalls, R. R., Tuomanen, E., Dziarski, R., & Golenbock, D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.1 · Cited by 1,234
Characterization of the 1918 influenza virus polymerase genes
Taubenberger, J. K., Reid, A. H., Lourens, R. M., Wang, R., Jin, G., & Fanning, T. G. (2005) · Nature · doi:10.1038/nature04230 · Cited by 1,066 · cited 1×
“Pandemics may also result from direct transfer to and adaptation in humans of a whole avian influenza virus, however, as is suspected to have occurred in or just before 1918 (148).”
BackgroundA novel influenza A virus mitochondrial protein that induces cell death
Chen, W., Calvo, P. A., Malide, D., Gibbs, J., Schubert, U., Bacik, I., Basta, S., O'Neill, R., Schickli, J., Palese, P., et al. (2001) · Nature Medicine · doi:10.1038/nm1201-1306 · Cited by 1,040 · cited 1×
“Data from our lab suggest that PB1-F2, a recently discovered proapoptotic protein encoded by most human influenza A viruses (19, 50), contributes to this inflammatory response (J.”
BackgroundTreanor, J. J., Hayden, F. G., Vrooman, P. S., Barbarash, R., Bettis, R., Riff, D., Singh, S., Kinnersley, N., Ward, P., Mills, R. G., et al. (2000) · JAMA · doi:10.1001/jama.283.8.1016 · Cited by 1,014
(2019) · ASM Press eBooks · doi:10.1128/9781683670131 · Cited by 1,009
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Belshe, R. B., Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382002 · Cited by 916
Cutts, F., Zaman, S., Enwere, G., Jaffar, S., Levine, O., Okoko, J., Oluwalana, C., Vaughan, A., Obaro, S., Leach, A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71876-6 · Cited by 900 · cited 3×
“The burden of pneumococcal disease in both adults and children in developing countries where the vaccine is not available is considerably higher than that in the United States (11, 18, 33, 44).”
BackgroundInfluentialCheung, C., Poon, L., Lau, A., Luk, W., Lau, Y., Shortridge, K., Gordon, S., Guan, Y., & Peiris, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11772-7 · Cited by 889 · cited 1×
“Similar findings for humans with highly pathogenic H5N1 avian influenza viruses provide further support for this concept (8, 21).”
ResultBacteremia among Children Admitted to a Rural Hospital in Kenya
Berkley, J. A., Lowe, B. S., Mwangi, I., Williams, T., Bauni, E., Mwarumba, S., Ngetsa, C., Slack, M. P. E., Njenga, S., Hart, C. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa040275 · Cited by 851 · cited 3×
“The burden of pneumococcal disease in both adults and children in developing countries where the vaccine is not available is considerably higher than that in the United States (11, 18, 33, 44).”
BackgroundInfluentialGray, B. M., Converse, G. M., & Dillon, H. C. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/142.6.923 · Cited by 796 · cited 1×
“for transmission to vulnerable populations (56, 57, 71).”
BackgroundCundell, D. R., Gerard, N. P., Gerard, C., Idanpaan-Heikkila, I., & Tuomanen, E. I. (1995) · Nature · doi:10.1038/377435a0 · Cited by 741 · cited 1×
“The expression of PAF-R is upregulated by inflammatory cytokines (32) and has been shown to be an important factor in the transition from the blood to the cerebrospinal fluid during the induction of meningitis (117).”
BackgroundInfluenza virus neuraminidase inhibitors
Gubareva, L. V., Kaiser, L., & Hayden, F. G. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11433-8 · Cited by 730 · cited 1×
“from infected cells and to spread through mucinous secretions (58).”
BackgroundEpidemiology and Clinical Characteristics of Community-Acquired Pneumonia in Hospitalized Children
Michelow, I. C., Olsen, K., Lozano, J., Rollins, N. K., Duffy, L. B., Ziegler, T., Kauppila, J., Leinonen, M., & McCracken, G. H. (2004) · Pediatrics · doi:10.1542/peds.113.4.701 · Cited by 711 · cited 1×
“and 54% of coinfections with a viral pathogen (109).”
BackgroundOral oseltamivir treatment of influenza in children
WHITLEY, R. J., HAYDEN, F. G., REISINGER, K. S., YOUNG, N., DUTKOWSKI, R., IPE, D., MILLS, R. G., & WARD, P. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200102000-00002 · Cited by 711
Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection
Malley, R., Henneke, P., Morse, S. C., Cieslewicz, M. J., Lipsitch, M., Thompson, C. M., Kurt-Jones, E., Paton, J. C., Wessels, M. R., & Golenbock, D. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435928100 · Cited by 704 · cited 2×
“Pneumolysin is recognized by TLR4 (15, 92), leading to a MyD88-independent signaling cascade mediated by IRF3 and STAT1 but also leading to NF- B activation through TRAF6 (13).”
BackgroundPandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution
Simonsen, L., Clarke, M. J., Schonberger, L. B., Arden, N. H., Cox, N. J., & Fukuda, K. (1998) · Journal of Infectious Diseases · doi:10.1086/515616 · Cited by 704 · cited 1×
“(128, 136) (C) and were calculated by different methods.”
MethodThe Economic Impact of Pandemic Influenza in the United States: Priorities for Intervention
Meltzer, M. I., Cox, N. J., & Fukuda, K. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0505.990507 · Cited by 695 · cited 1×
“The potential toll from the next pandemic is staggering; the mortality from a mild pandemic has been conservatively estimated at 89,000 to 207,000 deaths in the United States alone (108), a figure that could be greatly exceeded if the H5N1 strains endemic in Southeast Asia retain their virulence after achieving widesp…”
BackgroundGuillot, L., Le Goffic, R., Bloch, S., Escriou, N., Akira, S., Chignard, M., & Si-Tahar, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410592200 · Cited by 689 · cited 3×
“TLR7 and TLR8 signal through pathways similar to those stimulated by TLR2, requiring MyD88 and leading to NF- B activation, while TLR3 utilizes the same MyD88-independent pathway as TLR4, leading to IRF3 and STAT1 activation (13).”
Hayden, F. G., Fritz, R., Lobo, M. C., Alvord, W., Strober, W., & Straus, S. E. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1355 · Cited by 677 · cited 1×
“IL-1, IL-6, TNF- , RANTES, MIP-1-alpha, IL-8, and gamma interferon (62, 74).”
Lexau, C. A. (2005) · JAMA · doi:10.1001/jama.294.16.2043 · Cited by 671 · cited 1×
“3 cases of invasive pneumonia per 1,000 adults over the age of 50 years detectable by active surveillance since widespread implementation of the vaccine (84).”
BackgroundAre We Ready for Pandemic Influenza?
Webby, R. J., & Webster, R. G. (2003) · Science · doi:10.1126/science.1090350 · Cited by 655
(2013) · Wiley eBooks · doi:10.1002/9781118636817 · Cited by 653
The impact of influenza epidemics on mortality: introducing a severity index.
Simonsen, L., Clarke, M. J., Williamson, G. D., Stroup, D. F., Arden, N. H., & Schonberger, L. B. (1997) · American Journal of Public Health · doi:10.2105/ajph.87.12.1944 · Cited by 587
Options for the control of influenza III
Ada, G. L., Tannock, G. A., & Hampson, A. W. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00191-0 · Cited by 587
Impact of Respiratory Virus Infections on Persons With Chronic Underlying Conditions
Glezen, W. P. (2000) · JAMA · doi:10.1001/jama.283.4.499 · Cited by 559 · cited 1×
“In patients with preexisting lung disease such as chronic obstructive pulmonary disease, influenza predisposes to chronic bronchitis, exacerbations of chronic obstructive pulmonary disease, and pneumonia (20, 53, 140, 141).”
BackgroundImpact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.265 · Cited by 543 · cited 1×
“(139), the trend in reduction of serious wintertime illness in”
BackgroundTumpey, T. M., García-Sastre, A., Taubenberger, J. K., Palese, P., Swayne, D. E., Pantin-Jackwood, M. J., Schultz-Cherry, S., Solórzano, A., Van Rooijen, N., Katz, J. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14933-14944.2005 · Cited by 507
Kaiser, L., Wat, C., Mills, T., Mahoney, P., Ward, P., & Hayden, F. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1667 · Cited by 501
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Rosenow, C., Ryan, P., Weiser, J. N., Johnson, S., Fontan, P., Ortqvist, A., & Masure, H. R. (1997) · Molecular Microbiology · doi:10.1111/j.1365-2958.1997.mmi494.x · Cited by 481 · cited 1×
“One proposed mediator of this process is the receptor for platelet activating factor (PAF-R), a ubiquitous G-coupled protein to which phosphorylcholine expressed on the surface of the pneumococcus can adhere (31, 129).”
BackgroundSTUDIES ON INFLUENZA IN THE PANDEMIC OF 1957-1958. II. PULMONARY COMPLICATIONS OF INFLUENZA*†
Louria, D. B., Blumenfeld, H. L., Ellis, J. T., Kilbourne, E. D., & Rogers, D. E. (1959) · Journal of Clinical Investigation · doi:10.1172/jci103791 · Cited by 479 · cited 4×
“However, in most cases of secondary bacterial infection leukocytosis, not leukopenia, is a prominent clinical sign, with a preponderance of polymorphonuclear cells and immature forms (90, 94, 95, 156).”
BackgroundInfluentialThe Impact of Influenza Epidemics on Hospitalizations
Simonsen, L., Fukuda, K., Schonberger, L. B., & Cox, N. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315320 · Cited by 476 · cited 1×
“H3N2 subtype viruses were also associated with a higher rate of P&I hospitalization over 26 influenza seasons from 1970 to 1995 (138).”
BackgroundInfluenza and the Winter Increase in Mortality in the United States, 1959-1999
Reichert, T. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh227 · Cited by 451 · cited 1×
“(128, 136) (C) and were calculated by different methods.”
MethodSERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS
GLEZEN, W. P. (1982) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036250 · Cited by 449 · cited 1×
“Since NAs from N2 subtype influenza viruses have generally higher activity than recent N1 or influenza B virus NAs, this observation might partially explain why virulence and excess P&I mortality have been higher over the last 3 decades in years when H3N2 viruses circulate (52, 137, 149, 169).”
BackgroundMcCullers, J. A., & Rehg, J. E. (2002) · The Journal of Infectious Diseases · doi:10.1086/341462 · Cited by 423 · cited 7×
“In mice secondarily infected with pneumococcus after infection with PR8, bacterial loads were increased in the lungs, and bacteria could be seen to adhere to areas of the respiratory tract damaged by the cytotoxicity of the virus (61, 125).”
BackgroundInfluentialSelf-citationRole of Neuraminidase in Lethal Synergism between Influenza Virus and Streptococcus pneumoniae
McCullers, J. A., & Bartmess, K. C. (2003) · The Journal of Infectious Diseases · doi:10.1086/368163 · Cited by 386 · cited 2×
“activity of the virus enhanced adherence of pneumococcus to epithelial cells in vitro and predisposed to fatal pneumonia (102).”
BackgroundSelf-citationCooper, N. J., Sutton, A. J., Abrams, K. R., Wailoo, A., Turner, D., & Nicholson, K. G. (2003) · BMJ · doi:10.1136/bmj.326.7401.1235 · Cited by 357
Julkunen, I. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00026-5 · Cited by 354
Wizemann, T. M., Heinrichs, J. H., Adamou, J. E., Erwin, A. L., Kunsch, C., Choi, G. H., Barash, S. C., Rosen, C. A., Masure, H. R., Tuomanen, E., et al. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1593-1598.2001 · Cited by 351 · cited 1×
“surface proteins, many of which play a role in pathogenicity and virulence (166).”
Backgroundvan der Sluijs, K. F., van Elden, L. J. R., Nijhuis, M., Schuurman, R., Pater, J. M., Florquin, S., Goldman, M., Jansen, H. M., Lutter, R., & van der Poll, T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7603 · Cited by 334 · cited 1×
“proposed that IL-10 was the key mediator of this dysfunctional process, since it has an inhibitory effect on the function of neutrophils during pneumococcal pneumonia (157, 158).”
BackgroundTissue‐Specific Contributions of Pneumococcal Virulence Factors to Pathogenesis
Orihuela, C. J., Gao, G., Francis, K. P., Yu, J., & Tuomanen, E. I. (2004) · The Journal of Infectious Diseases · doi:10.1086/424596 · Cited by 326 · cited 2×
“The expression of PAF-R is upregulated by inflammatory cytokines (32) and has been shown to be an important factor in the transition from the blood to the cerebrospinal fluid during the induction of meningitis (117).”
BackgroundEchchannaoui, H., Frei, K., Schnell, C., Leib, S. L., Zimmerli, W., & Landmann, R. (2002) · The Journal of Infectious Diseases · doi:10.1086/342845 · Cited by 303 · cited 1×
“pneumoniae is recognized by TLR2, resulting in NF- B activation through pathways involving MyD88 and other cofactors and intermediates (42, 78, 79, 170).”
BackgroundTransforming growth factor β: a matter of life and death
McCartney-Francis, N. L., & Wahl, S. M. (1994) · Journal of Leukocyte Biology · doi:10.1002/jlb.55.3.401 · Cited by 299
Clements, D. A. (1995) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1995.02170230067009 · Cited by 298 · cited 1×
“signed to evaluate effects on otitis media (23, 65).”
BackgroundInfluenza Vaccination in the Prevention of Acute Otitis Media in Children
Heikkinen, T. (1991) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1991.02160040103017 · Cited by 287 · cited 1×
“signed to evaluate effects on otitis media (23, 65).”
BackgroundSpread of Streptococcus pneumoniae in Families. I. Carriage Rates and Distribution of Types
Owen Hendley, J., Sande, M. A., Stewart, P. M., & Gwaltney, J. M. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/132.1.55 · Cited by 285
Clinical effectiveness of influenza vaccination in Manitoba.
Fedson, D. S. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510160074032 · Cited by 278
Role of Staphylococcus protease in the development of influenza pneumonia
Tashiro, M., Ciborowski, P., Klenk, H.-D., Pulverer, G., & Rott, R. (1987) · Nature · doi:10.1038/325536a0 · Cited by 273
Role of Novel Choline Binding Proteins in Virulence of Streptococcus pneumoniae
Gosink, K. K., Mann, E. R., Guglielmo, C., Tuomanen, E. I., & Masure, H. R. (2000) · Infection and Immunity · doi:10.1128/iai.68.10.5690-5695.2000 · Cited by 267 · cited 1×
“To this point we have examined only one of these candidates, choline binding protein G (CbpG), a multifunctional protein that shares sequence homology with serine proteases (55, 93).”
BackgroundPyruvate oxidase, as a determinant of virulence in Streptococcus pneumoniae
Spellerberg, B., Cundell, D. R., Sandros, J., Pearce, B. J., Idänpään‐Heikkilä, I., Rosenow, C., & Masure, H. R. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.425954.x · Cited by 264
Christenson, B., Lundbergh, P., Hedlund, J., & Örtqvist, Å. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04237-9 · Cited by 262
Importance of Respiratory Viruses in Acute Otitis Media
Heikkinen, T., & Chonmaitree, T. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.230-241.2003 · Cited by 260 · cited 1×
“Respiratory viruses can be detected in the nasopharynxes of up to 90% of children with AOM and in the middle ear fluid of 20% (64).”
BackgroundInterieukin-10 Impairs Host Defense in Murine Pneumococcal Pneumonia
van der Poll, T., Marchant, A., Keogh, C. V., Goldman, M., & Lowry, S. F. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.5.994 · Cited by 255 · cited 1×
“proposed that IL-10 was the key mediator of this dysfunctional process, since it has an inhibitory effect on the function of neutrophils during pneumococcal pneumonia (157, 158).”
BackgroundBerry, A. M., & Paton, J. C. (2000) · Infection and Immunity · doi:10.1128/iai.68.1.133-140.2000 · Cited by 255 · cited 1×
“(17) and is thought to produce a third (12).”
BackgroundEpidemiological evidence of an early wave of the 1918 influenza pandemic in New York City
Olson, D. R., Simonsen, L., Edelson, P. J., & Morse, S. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408290102 · Cited by 254 · cited 1×
“However, P&I deaths accounted for 98% of all influenza-related deaths in 1918 to 1919 and 54% to 63% in 1928 to 1929 but for only 24% to 35% in 1943 to 1944 (27, 116).”
Nordin, J., Mullooly, J., Poblete, S., Strikas, R., Petrucci, R., Wei, F., Rush, B., Safirstein, B., Wheeler, D., & Nichol, K. L. (2001) · The Journal of Infectious Diseases · doi:10.1086/323085 · Cited by 251
Role ofToll-Like Receptor 4 in Gram-Positive and Gram-Negative Pneumonia inMice
Branger, J., Knapp, S., Weijer, S., Leemans, J. C., Pater, J. M., Speelman, P., Florquin, S., & van der Poll, T. (2004) · Infection and Immunity · doi:10.1128/iai.72.2.788-794.2004 · Cited by 247
Shope, R. E. (1931) · Journal of Experimental Medicine · doi:10.1084/jem.54.3.349 · Cited by 247
Influenza virus neuraminidase activates latent transforming growth factor beta
Schultz-Cherry, S., & Hinshaw, V. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.12.8624-8629.1996 · Cited by 244 · cited 1×
“can activate latent TGF- to its active form (133).”
BackgroundSandgren, A., Sjöström, K., Olsson‐Liljequist, B., Christensson, B., Samuelsson, A., Kronvall, G., & Henriques Normark, B. (2004) · The Journal of Infectious Diseases · doi:10.1086/381686 · Cited by 238
Plotkowski, M.-C., Puchelle, E., Beck, G., Jacquot, J., & Hannoun, C. (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.134.5.1040 · Cited by 231
Cytokine Kinetics and Other Host Factors in Response to Pneumococcal Pulmonary Infection in Mice
Bergeron, Y., Ouellet, N., Deslauriers, A.-M., Simard, M., Olivier, M., & Bergeron, M. G. (1998) · Infection and Immunity · doi:10.1128/iai.66.3.912-922.1998 · Cited by 227 · cited 5×
“We have found that certain cytokines, including TNF- , IL-1, IL-6, and IL-10, as well as the neutrophil- and macrophage-chemoattractant chemokines KC and MIP-1 , are strikingly elevated in mice with secondary pneumococcal pneumonia in our model (141a).”
BackgroundInfluentialGibbs, J. S., Malide, D., Hornung, F., Bennink, J. R., & Yewdell, J. W. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7214-7224.2003 · Cited by 224 · cited 1×
“Data from our lab suggest that PB1-F2, a recently discovered proapoptotic protein encoded by most human influenza A viruses (19, 50), contributes to this inflammatory response (J.”
BackgroundKoedel, U., Angele, B., Rupprecht, T., Wagner, H., Roggenkamp, A., Pfister, H.-W., & Kirschning, C. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.438 · Cited by 223
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
Peltola, V. T., Murti, K. G., & McCullers, J. A. (2005) · The Journal of Infectious Diseases · doi:10.1086/430954 · Cited by 219 · cited 8×
“served differences in excess mortality (122).”
BackgroundInfluentialSelf-citationExcess Mortality from Causes Other than Influenza and Pneumonia during Influenza Epidemics
Collins, S. D. (1932) · Public Health Reports (1896-1970) · doi:10.2307/4580606 · Cited by 198
A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting
HUSSAIN, M., MELEGARO, A., PEBODY, R. G., GEORGE, R., EDMUNDS, W. J., TALUKDAR, R., MARTIN, S. A., EFSTRATIOU, A., & MILLER, E. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805004012 · Cited by 188 · cited 1×
“for transmission to vulnerable populations (56, 57, 71).”
Background&NA; (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199910001-00004 · Cited by 179
Streptococcus pneumoniae: Invasion and Inflammation
Loughran, A. J., Orihuela, C. J., & Tuomanen, E. I. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0004-2018 · Cited by 175
Fedson, D. S., Anthony, J., & Scott, G. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00122-x · Cited by 167
The innate immune response to pneumococcal lung infection: the untold story
Kadioglu, A., & Andrew, P. W. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.12.006 · Cited by 166 · cited 1×
“Recognition of pathogen-associated molecular patterns by pattern recognition receptors such as the Toll-like receptors (TLRs) leads to activation of signaling cascades and the generation of an inflammatory response (75).”
BackgroundDeveloping animal models for polymicrobial diseases
Bakaletz, L. O. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro928 · Cited by 162 · cited 1×
“It is thought that certain pairings of organisms better complement each other than other potential pairings (7).”
BackgroundEffect of Antiviral Treatment on the Outcome of Secondary Bacterial Pneumonia after Influenza
McCullers, J. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/421525 · Cited by 162 · cited 1×
“The secondary bacterial pneumonia could be prevented or treated using an inhibitor of the influenza virus NA, independent of the effect on viral lung load (101, 102).”
BackgroundSelf-citationMultiple Genotypes of Influenza B Virus Circulated between 1979 and 2003
McCullers, J. A., Saito, T., & Iverson, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12817-12828.2004 · Cited by 159 · cited 1×
“This occurs commonly in humans with both influenza A and B viruses (87, 105).”
BackgroundSelf-citationMyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS
Koedel, U., Rupprecht, T., Angele, B., Heesemann, J., Wagner, H., Pfister, H., & Kirschning, C. J. (2004) · Brain · doi:10.1093/brain/awh171 · Cited by 156 · cited 1×
“pneumoniae is recognized by TLR2, resulting in NF- B activation through pathways involving MyD88 and other cofactors and intermediates (42, 78, 79, 170).”
BackgroundSynergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity.
Tashiro, M., Ciborowski, P., Reinacher, M., Pulverer, G., Klenk, H.-D., & Rott, R. (1987) · Virology · doi:10.1016/0042-6822(87)90284-4 · Cited by 152 · cited 1×
“aureus and concentrated in vitro are able to cleave the HA, supporting the hypothesis (147).”
Synergistic proinflammatory responses induced by polymicrobial colonization of epithelial surfaces
Ratner, A. J., Lysenko, E. S., Paul, M. N., & Weiser, J. N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500599102 · Cited by 142 · cited 1×
“demonstrated synergistic activation of proinflammatory cytokines with resulting neutrophil accumulation, albeit in a TLR-independent manner (127).”
BackgroundWilliam Farr: Founder of Modern Concepts of Surveillance
Langmuir, A. D. (1976) · International Journal of Epidemiology · doi:10.1093/ije/5.1.13 · Cited by 139 · cited 1×
“Using this concept, he developed in detail the methodology used today to quantitate mortality in influenza epidemics (43, 82).”
MethodClinical and epidemiologic studies of pneumococcal infection in children
GRAY, B. M., & DILLON, H. C. (1986) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198603000-00009 · Cited by 137 · cited 1×
“for transmission to vulnerable populations (56, 57, 71).”
BackgroundThe Global epidemiology of infectious diseases
Murray, C. J. L., López, A. D., & Mathers, C. D. (2004) · Cited by 135
The role of antivirals in the control of influenza
Monto, A. S. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00075-6 · Cited by 130
Smith, M. W., Schmidt, J. E., Rehg, J. E., Orihuela, C. J., & McCullers, J. A. (2007) · PubMed · Cited by 123
Self-citationMicrobiological and Inflammatory Factors Associated with the Development of Pneumococcal Pneumonia
Dallaire, F., Ouellet, N., Bergeron, Y., Turmel, V., Gauthier, M., Simard, M., & Bergeron, M. G. (2001) · The Journal of Infectious Diseases · doi:10.1086/322021 · Cited by 114 · cited 5×
“We have found that certain cytokines, including TNF- , IL-1, IL-6, and IL-10, as well as the neutrophil- and macrophage-chemoattractant chemokines KC and MIP-1 , are strikingly elevated in mice with secondary pneumococcal pneumonia in our model (141a).”
BackgroundInfluentialAbramson, J. S., Giebink, G. S., & Quie, P. G. (1982) · Infection and Immunity · doi:10.1128/iai.36.1.289-296.1982 · Cited by 114
The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro
Feldman, C. H., Mitchell, T. J., Andrew, P. W., Boulnois, G. J., Read, R. C., Todd, H. C., COLE, P. J., & Wilson, R. (1990) · Microbial Pathogenesis · doi:10.1016/0882-4010(90)90016-j · Cited by 113
Proinflammatory Interactions of Pneumolysin with Human Neutrophils
Cockeran, R., Theron, A. J., Steel, H. C., Matlola, N. M., Mitchell, T. J., Feldman, C. H., & Anderson, R. (2001) · The Journal of Infectious Diseases · doi:10.1086/318536 · Cited by 110 · cited 1×
“Activated neutrophils and macrophages in the lung may contribute to the severity of infection by expression of inflammatory mediators, leading to tissue damage (161), particularly when combined with cytotoxins from the bacteria (24).”
BackgroundOtitis Media: The Chinchilla Model1
Giebink, G. S. (1999) · Microbial Drug Resistance · doi:10.1089/mdr.1999.5.57 · Cited by 109
Bridy‐Pappas, A. E., Margolis, M. B., Center, K. J., & Isaacman, D. J. (2005) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.9.1193 · Cited by 108 · cited 1×
“The pneumococcus has historically been the most common etiologic agent of community-acquired pneumonia, as well as bacterial meningitis, otitis media, and sepsis (16, 44, 118, 168).”
BackgroundPULMONARY COMPLICATIONS OF INFLUENZA
Scadding, J. G. (1952) · The Lancet · doi:10.1016/s0140-6736(52)92362-3 · Cited by 107
Lewis, P. A., & Shope, R. E. (1931) · Journal of Experimental Medicine · doi:10.1084/jem.54.3.361 · Cited by 107
DIFFERING VIRULENCE OF H1N1 AND H3N2 INFLUENZA STRAINS
WRIGHT, P. F., THOMPSON, J., & KARZON, D. T. (1980) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113053 · Cited by 106 · cited 1×
“Since NAs from N2 subtype influenza viruses have generally higher activity than recent N1 or influenza B virus NAs, this observation might partially explain why virulence and excess P&I mortality have been higher over the last 3 decades in years when H3N2 viruses circulate (52, 137, 149, 169).”
BackgroundReceptors in the Pseudomonas Aeruginosa Adherence to Injured and Repairing Airway Epithelium
de Bentzmann, S., Plotkowski, C., & Puchelle, E. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.4_pt_2.s155 · Cited by 106 · cited 1×
“liferation and regeneration response (35, 124).”
Interactions between Viruses and Bacteria in Patients with Chronic Bronchitis
Smith, C. B., Golden, C., Klauber, M. R., Kanner, R., & Renzetti, A. (1976) · Journal of Infectious Diseases · doi:10.1093/infdis/134.6.552 · Cited by 106
MARTIN, C. M. (1959) · A M A Archives of Internal Medicine · doi:10.1001/archinte.1959.00270040001001 · Cited by 102 · cited 2×
“However, in most cases of secondary bacterial infection leukocytosis, not leukopenia, is a prominent clinical sign, with a preponderance of polymorphonuclear cells and immature forms (90, 94, 95, 156).”
BackgroundEFFECT OF THE LESION DUE TO INFLUENZA VIRUS ON THE RESISTANCE OF MICE TO INHALED PNEUMOCOCCI
Harford, C. G., Leidler, V., Hara, M., & Hamlin, W. T. T. A. O. A. (1949) · Journal of Experimental Medicine · doi:10.1084/jem.89.1.53 · Cited by 99 · cited 4×
“The concept that influenza virus-induced epithelial damage provides increased numbers of attachment sites for bacteria is supported by mouse studies using the highly pathogenic, mouse-adapted virus PR8 (49, 61, 104, 107).”
InfluentialAbramson, J. S., Mills, E. L., Giebink, G. S., & Quie, P. G. (1982) · Infection and Immunity · doi:10.1128/iai.35.1.350-355.1982 · Cited by 96 · cited 1×
“poses that influenza virus-mediated dysfunction of immune effectors such as neutrophils might compromise local immunity at normally sterile sites such as the ear or alveolus, allowing pneumococcus to cause pyogenic infections (4).”
BackgroundBacterial sinusitis and otitis media following influenza virus infection in ferrets
Peltola, V. T., Boyd, K. L., McAuley, J. L., Rehg, J. E., & McCullers, J. A. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.2562-2567.2006 · Cited by 95
Self-citationLindstrom, S., Hiromoto, Y., Nerome, R., Omoe, K., Sugita, S., Yamazaki, Y., Takahashi, T., & Nerome, K. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8021-8031.1998 · Cited by 94 · cited 1×
“This occurs commonly in humans with both influenza A and B viruses (87, 105).”
BackgroundHedlund, J., Christenson, B., Lundbergh, P., & Örtqvist, Å. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00296-2 · Cited by 93
Vital Statistics: A Memorial Volume of Selections from the Reports and Writings of William Farr
FARR, W. B. (1975) · Medical Entomology and Zoology · Cited by 92
Harford, C. G., Hara, M., & Hamlin, W. T. T. A. O. A. (1950) · Journal of Experimental Medicine · doi:10.1084/jem.91.3.245 · Cited by 92 · cited 1×
“Obstruction of the small airways due to disruption of surfactant, increased mucinous secretions combined with fibrin and edema fluid, and an influx of inflammatory cells create dead space and a culture medium for bacteria (60, 89).”
BackgroundAsian Influenza A in Boston, 1957-1958: II. Severe Staphylococcal Pneumonia Complicating Influenza
MARTIN, C. M. (1959) · A M A Archives of Internal Medicine · doi:10.1001/archinte.1959.00270040018002 · Cited by 91 · cited 1×
“However, in most cases of secondary bacterial infection leukocytosis, not leukopenia, is a prominent clinical sign, with a preponderance of polymorphonuclear cells and immature forms (90, 94, 95, 156).”
BackgroundMolecular pathogenesis of pneumococcal pneumonia
McCullers, J. (2001) · Frontiers in Bioscience · doi:10.2741/mccullers · Cited by 89 · cited 1×
“Aside from adhesins that the bacterium uses to bind to these putative receptors, pneumococcus expresses several virulence factors that may help the process (106).”
BackgroundPolymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas.
Abramson, J. S., Giebink, G. S., Mills, E. L., & Quie, P. G. (1981) · Journal of Infectious Diseases · doi:10.1093/infdis/143.6.836 · Cited by 88
Invasive Pneumococcal Infections Among Hospitalized Children in Bamako, Mali
Campbell, J. D., Kotloff, K. L., Sow, S. O., Tapia, M. D., Keita, M. M., Keita, T., Diallo, S., Hormazábal, J. C., Murray, P. R., & Levine, M. M. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000130951.85974.79 · Cited by 85 · cited 3×
“The burden of pneumococcal disease in both adults and children in developing countries where the vaccine is not available is considerably higher than that in the United States (11, 18, 33, 44).”
BackgroundInfluentialTong, H. H., McIver, M. A., Fisher, L. M., & DeMaria, T. F. (1999) · Microbial Pathogenesis · doi:10.1006/mpat.1998.0257 · Cited by 77 · cited 1×
“mococcus in vitro to tracheal (152), eustachian tube (81), and”
BackgroundDunkin, G. W., & Laidlaw, P. P. (1926) · Journal of Comparative Pathology and Therapeutics · doi:10.1016/s0368-1742(26)80020-7 · Cited by 77
Multifunctional Role of Choline Binding Protein G in Pneumococcal Pathogenesis
Mann, B., Orihuela, C. J., Antikainen, J., Gao, G., Sublett, J. E., Korhonen, T. K., & TUOMANEN, E. I. (2006) · Infection and Immunity · doi:10.1128/iai.74.2.821-829.2006 · Cited by 74 · cited 1×
“To this point we have examined only one of these candidates, choline binding protein G (CbpG), a multifunctional protein that shares sequence homology with serine proteases (55, 93).”
BackgroundSmith, C. B., Kanner, R. E., Golden, C. A., Klauber, M. R., & Renzetti, A. D. (1980) · Journal of Infectious Diseases · doi:10.1093/infdis/141.3.271 · Cited by 71 · cited 1×
“In patients with preexisting lung disease such as chronic obstructive pulmonary disease, influenza predisposes to chronic bronchitis, exacerbations of chronic obstructive pulmonary disease, and pneumonia (20, 53, 140, 141).”
BackgroundLoosli, C. G., Stinson, S. F., Ryan, D. P., Hertweck, M. S., Hardy, J. D., & Serebrin, R. (1975) · CHEST Journal · doi:10.1378/chest.67.2_supplement.7s · Cited by 70 · cited 3×
“a regeneration and remodeling phase (89).”
BackgroundPAF Receptor Anchors Streptococcus Pneumoniae to Activated Human Endothelial Cells
Cundell, D. R., Gerard, C. J., Idänpään‐Heikkilä, I., TUOMANEN, E. I., & Gerard, N. P. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-0179-8_16 · Cited by 69 · cited 1×
“One proposed mediator of this process is the receptor for platelet activating factor (PAF-R), a ubiquitous G-coupled protein to which phosphorylcholine expressed on the surface of the pneumococcus can adhere (31, 129).”
BackgroundCellular and molecular mechanisms of bacterial adhesion to respiratory mucosa
Plotkowski, M., Bajolet-Laudinat, O., & Puchelle, E. (1993) · European Respiratory Journal · doi:10.1183/09031936.93.06060903 · Cited by 67 · cited 1×
“liferation and regeneration response (35, 124).”
Abrahams, A., Hallows, N., & French, H. (1919) · The Lancet · doi:10.1016/s0140-6736(01)22115-1 · Cited by 64
Synergism between respiratory viruses and bacteria.
Loosli, C. G. (1968) · PubMed Central · Cited by 63
Sellers, T. F., Schulman, J., Bouvier, C., McCune, R., & Kilbourne, E. D. (1961) · The Journal of Experimental Medicine · doi:10.1084/jem.114.2.237 · Cited by 60
EPIDEMIC PNEUMOCOCCAL PNEUMONIA
Hodges, R. G., & MacLeod, C. M. (1946) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119088 · Cited by 59
Combined Infection of Mice with H. Influenzae and Influenza Virus by the Intranasal Route
Francis, T., & De Torregrosa, M. V. (1945) · Journal of Infectious Diseases · doi:10.1093/infdis/76.1.70 · Cited by 56
Doyle, W. J., Skoner, D. P., Alper, C. M., Allen, G., Moody, S. A., Seroky, J. T., & Hayden, F. G. (1998) · The Journal of Infectious Diseases · doi:10.1086/515294 · Cited by 56
Pulmonary function in uncomplicated influenza.
JOHANSON, W. G., Pierce, A. K., & Sanford, J. P. (1969) · PubMed · doi:10.1164/arrd.1969.100.2.141 · Cited by 55
Trends and Epidemics of Influenza and Pneumonia, 1918-1951
Collins, S. D., & Lehmann, J. (1951) · Public Health Reports (1896-1970) · doi:10.2307/4587915 · Cited by 55 · cited 1×
“Data are derived from those of Collins and Lehmann (25, 27, 28) (A), Housworth and Spoon (70) (B), and Reichert et al.”
MethodPark, K., Coticchia, J. M., Bakaletz, L. O., & Lim, D. J. (1993) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348949310200711 · Cited by 54 · cited 2×
“Similar effects on ciliary activity are seen in the eustachian tube and contribute to otitis media (119).”
BackgroundStöhr, K. (2003) · BMJ · doi:10.1136/bmj.326.7401.1223 · Cited by 53 · cited 1×
“Despite the availability of effective antiviral drugs and vaccines, the World Health Organization estimates that annual influenza epidemics cause 3 to 5 million severe illnesses and 250,000 to 500,000 deaths each year in the developed world alone (143).”
BackgroundInfluenza: Observations on the Recovery of Virus from Man and on the Antibody Content of Human Sera
Andrewes, C. H., Laidlaw, P. P., & Smith, W. (1935) · PubMed Central · Cited by 52
Effects of Infection with Influenza Virus on the Function of Polymorphonuclear Leukocytes
Martin, R. R., Couch, R. B., Greenberg, S. B., Cate, T. R., & Warr, G. A. (1981) · The Journal of Infectious Diseases · doi:10.1093/infdis/144.3.279 · Cited by 50 · cited 1×
“Although these cells may be present in great numbers in the lung, various functional capabilities necessary for the clearance of bacteria may be altered, including chemotaxis, phagocytosis, and bacterial killing (30, 96).”
BackgroundTong, H. H., James, M. A., Grants, I. S., Liu, X., Shi, G., & DeMaria, T. F. (2001) · Microbial Pathogenesis · doi:10.1006/mpat.2001.0473 · Cited by 49
Alymova, I. V., Portner, A., Takimoto, T., Boyd, K. L., Babu, Y. S., & McCullers, J. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.398-405.2005 · Cited by 47 · cited 1×
“However, both Sendai virus and influenza virus, at low doses that induce minimal pathology, can support secondary invasion (5, 104).”
BackgroundSelf-citationTong, H. H., Kosunick, G. M., Fisher, L. M., & DeMaria, T. F. (2000) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348940010901106 · Cited by 46 · cited 1×
“that it supports coinfections between influenza and pneumococcus (51, 150).”
BackgroundEPIDEMIC PNEUMOCOCCAL PNEUMONIA
Hodges, R. G., MacLeod, C. M., & Bernhard, W. G. (1946) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a119090 · Cited by 45
Laidlaw, P. P., & Dunkin, G. W. (1926) · Journal of Comparative Pathology and Therapeutics · doi:10.1016/s0368-1742(26)80022-0 · Cited by 45
(1937) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068294 · Cited by 43 · cited 1×
“Once the viral etiology of influenza was firmly established, a series of detailed studies on the pathology, bacteriology, and epidemiology of bacterial pneumonia during influenza followed over the next decade (47, 97, 120, 132, 145, 156).”
BackgroundAsian influenza A in Boston, 1957-1958
Cm, M. (1959) · JAMA Internal Medicine · Cited by 42
Modifications of lung clearance mechanisms by acute influenza A infection.
Levandowski, R. A., Gerrity, T. R., & Garrard, C. S. (1985) · PubMed · Cited by 40
Linder, T. E., LIM, D. J., & DeMaria, T. F. (1992) · Microbial Pathogenesis · doi:10.1016/0882-4010(92)90039-q · Cited by 40 · cited 1×
“middle ear (86) epithelia in an organ perfusion model using”
MethodREACTIONS OF MONKEYS TO EXPERIMENTALLY INDUCED INFLUENZA VIRUS A INFECTION
Saslaw, S., Wilson, H. E., Doan, C. A., Woolpert, O. C., & Schwab, J. L. (1946) · Journal of Experimental Medicine · doi:10.1084/jem.84.2.113 · Cited by 39 · cited 1×
“The leukopenia, granulocytopenia, and severity of viral disease were worsened by stressors such as cold and nutritional deficiencies (131).”
REACTIONS OF MONKEYS TO EXPERIMENTAL MIXED INFLUENZA AND STREPTOCOCCUS INFECTIONS
Wilson, H. E., Saslaw, S., Doan, C. A., Woolpert, O. C., & Schwab, J. L. (1947) · Journal of Experimental Medicine · doi:10.1084/jem.85.2.199 · Cited by 38 · cited 5×
“Insights into the Interaction between Influenza Virus and Pneumococcus Jonathan A. McCullers* Department of Infectious Diseases, St. Jude Children’s Research Hospital, 332 North Lauderdale Street, Memphis, Tennessee 38105-2794 INTRODUCTION ...............................................................................…”
BackgroundInfluentialTHE RELATION OF INFLUENZA VIRUS AND BACTERIA IN THE ETIOLOGY OF PNEUMONIA 12
Maxwell, E. S., Ward, T. G., & Van Metre, T. E. (1949) · Journal of Clinical Investigation · doi:10.1172/jci102073 · Cited by 37 · cited 1×
“Once the viral etiology of influenza was firmly established, a series of detailed studies on the pathology, bacteriology, and epidemiology of bacterial pneumonia during influenza followed over the next decade (47, 97, 120, 132, 145, 156).”
BackgroundPulmonary endothelial and bronchiolar epithelial lesions induced by 4-ipomeanol in mice.
Durham, S. K., Boyd, M. R., & Castleman, W. L. (1985) · PubMed · Cited by 37
Dunkin, G. W., & Laidlaw, P. P. (1926) · Journal of Comparative Pathology and Therapeutics · doi:10.1016/s0368-1742(26)80021-9 · Cited by 37
Kleemola, M., Nokso‐Koivisto, J., Herva, E., Syrjänen, R., Lahdenkari, M., Kilpi, T. M., & Hovi, T. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.05.012 · Cited by 36 · cited 1×
“However, support from epidemiologic studies for specific interactions other than that between influenza virus and pneumococcus is lacking (77), and the question of whether certain viral and bacterial organisms work poorly together or antagonize each other has not been addressed.”
BackgroundEffect of uncomplicated, presumptive influenza on the diffusing capacity of the lung.
Horner, G. J., & Gray, F. D. (1973) · PubMed · doi:10.1164/arrd.1973.108.4.866 · Cited by 35 · cited 1×
“Pulmonary functional capacity and diffusion capacity are diminished (69, 72).”
BackgroundHOUSWORTH, W. J., & SPOON, M. M. (1971) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121329 · Cited by 35 · cited 1×
“Data are derived from those of Collins and Lehmann (25, 27, 28) (A), Housworth and Spoon (70) (B), and Reichert et al.”
MethodInfluenza-Pneumonia Mortality in a Group of about 95 Cities in the United States, 1920-1929
Collins, S. D. (1930) · Public Health Reports (1896-1970) · doi:10.2307/4579562 · Cited by 30 · cited 1×
“Data are derived from those of Collins and Lehmann (25, 27, 28) (A), Housworth and Spoon (70) (B), and Reichert et al.”
MethodCamara, M., Mitchell, T. J., Andrew, P. W., & Boulnois, G. J. (1991) · Infection and Immunity · doi:10.1128/iai.59.8.2856-2858.1991 · Cited by 30 · cited 1×
“(17) and is thought to produce a third (12).”
BackgroundEffect of virus infections on polymorph function in children.
Craft, A. W., Reid, M. M., & Low, W. T. (1976) · BMJ · doi:10.1136/bmj.1.6025.1570 · Cited by 30 · cited 1×
“Although these cells may be present in great numbers in the lung, various functional capabilities necessary for the clearance of bacteria may be altered, including chemotaxis, phagocytosis, and bacterial killing (30, 96).”
BackgroundExperimental Alteration of Chinchilla Middle Ear Mucosae by Bacterial Neuraminidase
LaMarco, K. L., Diven, W. F., & Glew, R. H. (1986) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348948609500319 · Cited by 30 · cited 1×
“mococcus in vitro to tracheal (152), eustachian tube (81), and”
BackgroundThe relationship between influenza and pneumonia
Stuart-Harris, C. H., Laird, J., Tyrrell, D. A. J., Kelsall, M. H., Franks, Z. C., & Pownall, M. (1949) · Epidemiology and Infection · doi:10.1017/s0022172400014789 · Cited by 29 · cited 1×
“Once the viral etiology of influenza was firmly established, a series of detailed studies on the pathology, bacteriology, and epidemiology of bacterial pneumonia during influenza followed over the next decade (47, 97, 120, 132, 145, 156).”
BackgroundVirus and Rickettsial Diseases
(1956) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1956.tb35581.x · Cited by 28
Observations ON INFLUENZA AND ITS COMPLICATIONS
Muir, R., & Wilson, G. H. (1919) · BMJ · doi:10.1136/bmj.1.3027.3 · Cited by 27
THE PULMONARY COMPLICATIONS OF INFLUENZA AS SEEN IN SHEFFIELD IN 1949
(1952) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a066653 · Cited by 27 · cited 2×
“Once the viral etiology of influenza was firmly established, a series of detailed studies on the pathology, bacteriology, and epidemiology of bacterial pneumonia during influenza followed over the next decade (47, 97, 120, 132, 145, 156).”
BackgroundINFLUENZA AND ITS COMPLICATIONS
STUART-HARRIS, C. H. (1959) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a069767 · Cited by 27 · cited 2×
“The association between influenza and bacterial pneumonia came into particular focus following the 1918 pandemic, during which an estimated 40 to 50 million persons died (126), most of them from secondary bacterial pneumonia (1, 112, 144, 164).”
BackgroundINFLUENZA VIRUS ISOLATIONS AND SEROLOGICAL STUDIES MADE IN BOSTON DURING THE WINTER OF 1943-1944
Finland, M., Barnes, M. W., & Samper, B. A. (1945) · Journal of Clinical Investigation · doi:10.1172/jci101597 · Cited by 26
INFLUENZA AND INFLUENZAL PNEUMONIA AT FORT RILEY, KANSAS: FROM SEPT. 15 TO NOV. 1, 1918
STONE, W. J., & SWIFT, G. W. (1919) · Journal of the American Medical Association · doi:10.1001/jama.1919.02610070025014 · Cited by 23 · cited 2×
“known associated virus” (144), “acts as a pioneer and prepares”
BackgroundA Study of Influenza in Boston during the Winter of 1940–1941
Pearson, H. E., Eppinger, E. C., Dingle, J. H., & Enders, J. F. (1941) · New England Journal of Medicine · doi:10.1056/nejm194111132252001 · Cited by 20 · cited 1×
“Once the viral etiology of influenza was firmly established, a series of detailed studies on the pathology, bacteriology, and epidemiology of bacterial pneumonia during influenza followed over the next decade (47, 97, 120, 132, 145, 156).”
BackgroundA mouse model of dual infection with influenza virus and Streptococcus pneumoniae
McCullers, J. A., & Webster, R. G. (2001) · International Congress Series · doi:10.1016/s0531-5131(01)00631-8 · Cited by 19 · cited 4×
“The concept that influenza virus-induced epithelial damage provides increased numbers of attachment sites for bacteria is supported by mouse studies using the highly pathogenic, mouse-adapted virus PR8 (49, 61, 104, 107).”
InfluentialSelf-citationChen, Y., Stewart, P., Dales, R., Johansen, H., Bryan, S. N., & Taylor, G. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.03.010 · Cited by 19
Collins, S. D. (1945) · Public Health Reports (1896-1970) · doi:10.2307/4585317 · Cited by 18 · cited 2×
“However, P&I deaths accounted for 98% of all influenza-related deaths in 1918 to 1919 and 54% to 63% in 1928 to 1929 but for only 24% to 35% in 1943 to 1944 (27, 116).”
MethodBACTERIOLOGICAL AND PATHOLOGICAL OBSERVATIONS ON INFLUENZA AS SEEN IN FRANCE DURING 1918
Wilson, W. J., & Steer, P. (1919) · BMJ · doi:10.1136/bmj.1.3047.634 · Cited by 17 · cited 1×
“The association between influenza and bacterial pneumonia came into particular focus following the 1918 pandemic, during which an estimated 40 to 50 million persons died (126), most of them from secondary bacterial pneumonia (1, 112, 144, 164).”
BackgroundComparison of Several Wild-Type Influenza Viruses in the Ferret Tracheal Organ Culture System
Hoke, C. H., Hopkins, J. A., Meiklejohn, G., & Mostow, S. R. (1979) · Clinical Infectious Diseases · doi:10.1093/clinids/1.6.946 · Cited by 17
Wolbach, S. B. (1919) · University of Michigan Library Repository · Cited by 15
Wherry, W. B., & Butterfield, C. T. (1920) · The Journal of Infectious Diseases · doi:10.1093/infdis/27.4.315 · Cited by 12
4-Ipomeanol-induced effects on Sendai viral pneumonia in mice.
Durham, S. K., Babish, J. G., & Castleman, W. L. (1987) · PubMed · Cited by 11
Translation of Selected Passages from De L’Auscultation Médiate
Packard, F. (1923) · PubMed Central · Cited by 11
A ferret model of synergism between influenza virus and Streptococcus pneumoniae
Peltola, V. T., Rehg, J. E., & McCullers, J. A. (2004) · International Congress Series · doi:10.1016/j.ics.2004.02.023 · Cited by 5 · cited 1×
“ferret model of pneumococcal otitis media and sinusitis following infection with naturally occurring viruses (121, 123).”
BackgroundSelf-citationInfluenza Mutations: Trying to Hit a Moving Target
McCullers, J. A. (2006) · Future Virology · doi:10.2217/17460794.1.3.255 · Cited by 3 · cited 1×
“ing mechanisms creates a quasispecies pool of viruses in which many variants exist (100).”
BackgroundSelf-citation
Research works printed but not linked: 2
- 1. Abrahams, A., N. Hallows, and H. French. 1919. A further investigation into influenzo-pneumococcal and influenzo-streptococcal septicaemia. Lancet 1919: 1-11.
- 73. Jordan, E. O. 1927. Epidemic influenza, p. 356-438. American Medical Association, Chicago, Ill.
Cited by
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903810 · Cited by 3,037
Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/591708 · Cited by 1,625
“National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (See the editorial commentary by McCullers, on pages XXX–XXX.) Background.”
BackgroundRuuskanen, O., Lahti, E., Jennings, L. C., & Murdoch, D. R. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61459-6 · Cited by 1,124
Innate immunity to influenza virus infection
Iwasaki, A., & Pillai, P. S. (2014) · Nature Reviews Immunology · doi:10.1038/nri3665 · Cited by 1,068
Nair, H., Brooks, W. A., Katz, M., Roca, A., Berkley, J. A., Madhi, S. A., Simmerman, J. M., Gordon, A., Sato, M., Howie, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61051-9 · Cited by 1,006
Metadata
- Authors
- McCullers, J. A.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Corresponding author
- McCullers, Jonathan A.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2006-07
- Volume
- 19
- Issue
- 3
- Pages
- 571-582
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC1539103
- OpenAlex
- W2154385325
- Cited by
- 846
- References
- 177
- Citations by year
- 2026: 17 · 2025: 29 · 2024: 21 · 2023: 33 · 2022: 42 · 2021: 42 · 2020: 67 · 2019: 28 · 2018: 48 · 2017: 41 · 2016: 40 · 2015: 52 · 2014: 47 · 2013: 76 · 2012: 51
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Lebanese Syrian Associated Charities
- National Institutes of Health (1k08ai049178-01)
- National Institute of Allergy and Infectious Diseases (AI-54802, AI66349, AI-49178, R21AI054802, R01AI066349)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza virus, Streptococcus pneumoniae, bacterial co-infection, secondary bacterial pneumonia, host-pathogen interaction, receptor up-regulation, epithelial regeneration, immunomodulation, inflammatory cascade, vaccine targets
- MeSH terms
- Humans, Influenza, Human, Influenza B virus, Pneumonia, Pneumococcal, Streptococcus pneumoniae, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N8 Subtype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.